Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …
RETRACTED: Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?
PK Agrawal, C Agrawal, G Blunden - Molecules, 2022 - mdpi.com
As the world desperately searches for ways to treat the coronavirus disease 2019 (COVID-
19) pandemic, a growing number of people are turning to herbal remedies. The Artemisia …
19) pandemic, a growing number of people are turning to herbal remedies. The Artemisia …
Novel investigational anti-SARS-CoV-2 agent ensitrelvir “S-217622”: a very promising potential universal broad-spectrum antiviral at the therapeutic frontline of …
Lately, nitrogenous heterocyclic antivirals, such as nucleoside-like compounds, oxadiazoles,
thiadiazoles, triazoles, quinolines, and isoquinolines, topped the therapeutic scene as …
thiadiazoles, triazoles, quinolines, and isoquinolines, topped the therapeutic scene as …
Promising experimental anti-SARS-CoV-2 agent “SLL-0197800”: the prospective universal inhibitory properties against the coming versions of the coronavirus
Isoquinoline derivatives having some nucleosidic structural features are considered as
candidate choices for effective remediation of the different severe acute respiratory …
candidate choices for effective remediation of the different severe acute respiratory …
Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: In Silico and In Vitro Studies
Lately, nucleos (t) ide antivirals topped the scene as top options for the treatment of
coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome …
coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome …
Potent dual polymerase/exonuclease inhibitory activities of antioxidant aminothiadiazoles against the COVID-19 omicron virus: a promising in silico/in vitro …
Recently, natural and synthetic nitrogenous heterocyclic antivirals topped the scene as first
choices for the treatment of the severe acute respiratory syndrome coronavirus 2 (SARS …
choices for the treatment of the severe acute respiratory syndrome coronavirus 2 (SARS …
Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B. 1.1. 529/BA. 2 subvariant: a repurposing research study
Mysterious evolution of a new strain of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the Omicron variant, led to a new challenge in the persistent coronavirus …
(SARS-CoV-2), the Omicron variant, led to a new challenge in the persistent coronavirus …
In silico identification of novel benzophenone–coumarin derivatives as SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitors
In this study, we propose our novel benzophenone–coumarin derivatives (BCDs) as potent
inhibitors of the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 virus, one of the …
inhibitors of the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 virus, one of the …
Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant
Abstract Nucleoside analogs/derivatives (NAs/NDs) with potent antiviral activities are now
deemed very convenient choices for the treatment of coronavirus disease 2019 (COVID-19) …
deemed very convenient choices for the treatment of coronavirus disease 2019 (COVID-19) …
[HTML][HTML] Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens-Epstein Barr virus and SARS-CoV-2, an in silico study
In malaria endemic countries, coinfections and cotransmissions of different viral pathogens
are widely reported. Prior studies have shown that malaria can trigger the Epstein-Barr virus …
are widely reported. Prior studies have shown that malaria can trigger the Epstein-Barr virus …